China all set to use unapproved vaccines for emergency usage

▴ China all set to use unapproved vaccines for emergency usage
China is dumping testing procedures, approves vaccines for emergency use

A Chinese health official on Saturday confirmed the country authorized emergency usage of COVID-19 vaccines developed by some select domestic companies on July 22.

“We’ve drawn up a series of plan packages, including medical consent forms, side-effects-monitoring plans, rescuing plans and compensation plans, to make sure the emergency use is well regulated and monitored,” Zheng Zhongwei, head of China’s coronavirus vaccine development task force, told broadcaster CCTV.

An emergency use authorization, which is based on Chinese vaccine management law, allows unapproved vaccine candidates to be used among people who are at high risk of getting infected on a limited period.

By first inoculating the special groups, like front-line medical workers and civil servants, the move is to ensure that a city can keep normal functions when a health crisis strikes, the law states.

Similar authorizations have been legalized in many countries. For example, US Food and Drug Administration allows unapproved medical products to be used in an emergency to diagnose, treat or prevent life-threatening diseases or conditions.

“We are planning to scale up the inoculating group to better prepare for a possible next wave in autumn and winter,” Zheng added.

China’s coronavirus vaccines will be priced close to cost, Zheng said.

“It does not mean that companies cannot make profits,” Zheng said. “Companies should decide on moderate profits, or reasonable profits based on costs.”

A potential coronavirus vaccine being developed by a unit of China National Pharmaceutical Group (Sinopharm) could cost no more than 1,000 yuan (US$144) for two shots, Sinopharm Chairman Liu Jingzhen told state media last week. “(The price) will definitely be lower than what Liu said,” Zheng said.

Meanwhile, a new coronavirus vaccine cultivated within insect cells by West China Hospital of Sichuan University in Chengdu has been approved for human trial, according to local government on Saturday.

Using insect cells to grow proteins for the coronavirus vaccine — a first in China — could speed up large-scale production.

Tags : #ChinaCovidNewsAug24 #ChinaVaccineNewsAug24 #Sinopharm #USFDA #UnapprovedVaccines #Worldcovidnesupdateaug24

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Scientists in Moscow Develop Fetal Phantom for Obstetric UltrasoundNovember 19, 2024
International Men’s Day: A Celebration of Strength, Vulnerability, and ChangeNovember 19, 2024
The Bloody Truth: Why Menstruation Is Still a Taboo in Indian SchoolsNovember 19, 2024
Toxic Air, Fragile Hearts: The Hidden Cost of Pollution on Heart Failure PatientsNovember 19, 2024
Government of Telangana Hosts the AI in Healthcare Summit – Road to BioAsia 2025November 18, 2024
In yet another groundbreaking medical milestone, Sarvodaya Hospital successfully performs India’s youngest cochlear implant on a 5- month old babyNovember 18, 2024
Sightsavers India in collaboration with AbbVie Therapeutics India Private Limited Hosted the 4th State-Level Consultation on ‘Prevention of Visual Impairment Caused by Glaucoma’November 16, 2024
Is Your Saree Hurting You? How Tight Waist Petticoats Could Trigger Skin CancerNovember 16, 2024
10 New-born Lives Lost: The Jhansi Hospital Fire That Shook India’s ConscienceNovember 16, 2024
Streax introduces revolutionary Shampoo Hair Colour in South India at accessible price point.November 15, 2024
The Silent Killer in Your Genes: Can Splicing Errors Unlock New Cancer Cures?November 15, 2024
Stress on a Schedule: What Your Gut Bacteria Know That You Don’tNovember 15, 2024
A Preventable Catastrophe: Why Are Children Still Dying from Measles?November 15, 2024
The University of Tasmania invites applications for Master of Marine and Antarctic ScienceNovember 14, 2024
ICMR’s Bold Bet: Can India’s Scientists Deliver World-First Health Breakthroughs?November 14, 2024
The Dark Reality Behind India’s Ayushman Bharat: Profits Before Patients?November 14, 2024
Not a Fan of Exercise? Here’s How Few Steps You Actually Need for Better HealthNovember 14, 2024
Shiprocket launches AI Powered Shiprocket Copilot to empower a Self-Reliant Digital Future for over 1,00,000+ Indian MSMEsNovember 13, 2024
AIIMS Darbhanga and More: Can PM Modi’s 12,000 Crore Investment Turn Bihar into India’s Next Growth Engine?November 13, 2024
Self-Made Survivor: How a Virologist Battled Breast Cancer with Her Own Lab-Grown VirusesNovember 13, 2024